Suppliers / Instapill

Instapill

India 233 employees Updated 9 July 2026

Instapill is a finished-dose manufacturer based in India. It appears in 11 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by MHRA (UK), US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 13 September 2024 as VAI. Customs aggregates show $518K of exports covering 64 molecules to 3 destinations in 2026 so far.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
11
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 13 September 2024 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Bengaluru, India 3014463103
BENGALURU SOUTH DISTRICT, India Not on file
Bengaluru Rural, India Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 11 1
MHRA (UK) None 1
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $518K 3

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Instapill

Does Instapill hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Instapill. It does have 11 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Instapill FDA-registered?
One site operated by Instapill carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Instapill's last inspection go?
The most recent inspection on record closed on 13 September 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Instapill manufacture?
3 registered sites are on record, in India (Bengaluru, Bengaluru South District and Bengaluru Rural). Every site is listed on this page with the register it came from.
Which regulators recognise Instapill's GMP?
Current GMP certificates are on record from MHRA (UK), US FDA and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Instapill comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 13 September 2024.

Comparable suppliers

Abbott Healthcare also in India Accent Pharmaceuticals Diagnostics also in India Accure Labs Pvt.Ltd also in India ACME Formulation also in India Acme Generics also in India

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts